A generic alternative indicated for Eye Care. This formulation supports the drainage of ocular fluid and assists in reducing intraocular pressure for improved visual health.
Utilized to manage intraocular pressure by addressing aqueous humor secretion to alleviate optic nerve damage and support long-term vision health in glaucoma patients.
Mechanism of Action
Dorzolamide inhibits the carbonic anhydrase enzyme in the ciliary processes of the eye. This reduces the secretion of fluid (aqueous humor), which lowers the internal pressure that otherwise damages the optic nerve.
Route of Administration
Ophthalmic
Onset Time
2 hours
Duration
8–12 hours
Contraindications
Severe renal impairment, Hypersensitivity to sulfonamides, Hyperchloremic acidosis
Information for Trusopt is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.